---
title: "Pomdoctor Limited (POM.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/POM.US.md"
symbol: "POM.US"
name: "Pomdoctor Limited"
industry: "Health Care Distributors"
datetime: "2026-05-20T07:21:09.530Z"
locales:
  - [en](https://longbridge.com/en/quote/POM.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/POM.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/POM.US.md)
---

# Pomdoctor Limited (POM.US)

## Company Overview

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company’s business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants.

| Item | Detail |
|------|--------|
| Industry | Health Care Distributors |
| Exchange | US Market |
| Website | [www.7lk.com](https://www.7lk.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:16.000Z

**Overall: C (0.44)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 8 / 16 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 17.81% |  |
| Net Profit YoY | -49.63% |  |
| P/B Ratio | -0.22 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 14364451.65 |  |
| Revenue | 56054063.95 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 15.65% | A |
| Profit Margin | -53.16% | E |
| Gross Margin | 13.07% | D |
| Revenue YoY | 17.81% | B |
| Net Profit YoY | -49.63% | D |
| Total Assets YoY | 142.76% | A |
| Net Assets YoY | -0.50% | D |
| Cash Flow Margin | 69.85% | C |
| OCF YoY | 17.81% | B |
| Turnover | 5.20 | A |
| Gearing Ratio | 547.48% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Pomdoctor Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "17.81%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-49.63%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-0.22",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "14364451.65",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "56054063.95",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "15.65%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-53.16%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "13.07%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "17.81%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-49.63%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "142.76%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "-0.50%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "69.85%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "17.81%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "5.20",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "547.48%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.48 | 8/16 | - | - | - |
| PB | -0.22 | 9/16 | - | - | - |
| PS (TTM) | 0.26 | 6/16 | 10.78 | 0.79 | 0.57 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Henry Schein (HSIC.US) | B | C | A | D | B | B |
| 02 | ZeroStack (ZSTK.US) | E | B | A | A | B | B |
| 03 | McKesson (MCK.US) | E | B | A | E | B | C |
| 04 | Cencora (COR.US) | B | B | A | E | C | C |
| 05 | Cardinal Health (CAH.US) | E | C | A | E | B | C |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/POM.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/POM.US/norm.md)
- [Related News](https://longbridge.com/en/quote/POM.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/POM.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**